Back
Royalty Pharma PLC Vs. Maravai LifeSciences Holdings Industry Stock Comparison
Sell
38
RPRX
Royalty Pharma PLC
Last Price:
27.86
Seasonality Move:
-2.02%
Buy
67
MRVI
Maravai LifeSciences Holdings
Last Price:
11.10
Seasonality Move:
0.38%
Sell
38
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $28.21. The Score for RPRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Maravai LifeSciences Holdings (MRVI)
is a Buy
Is Maravai LifeSciences Holdings a Buy, Sell or Hold?
- The current Maravai LifeSciences Holdings [MRVI] share price is $11.20. The Score for MRVI is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- MRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $28.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
MRVI Stock Price Chart
What is Maravai LifeSciences Holdings's stock price today?
-
The Maravai LifeSciences Holdings share price today is $11.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 47.19 | Sell |
| Chaikin Money Flow: | -466302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.79 - 28.45) | Buy |
| Bollinger Bands (100): | (27.98 - 30.06) | Sell |
MRVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 82.38 | Buy |
| Chaikin Money Flow: | 1484701 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.53 - 9.73) | Buy |
| Bollinger Bands (100): | (6.01 - 8.69) | Buy |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.18 | Buy |
| 20-day SMA: | 28.11 | Buy |
| 50-day SMA: | 29.01 | Sell |
| 200-day SMA: | 28.6 | Sell |
| 8-day EMA: | 28.18 | Buy |
| 20-day EMA: | 28.28 | Sell |
| 50-day EMA: | 28.68 | Sell |
| 200-day EMA: | 29.65 | Sell |
MRVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.95 | Buy |
| 20-day SMA: | 8.74 | Buy |
| 50-day SMA: | 8.37 | Buy |
| 200-day SMA: | 7.75 | Buy |
| 8-day EMA: | 10.11 | Buy |
| 20-day EMA: | 9.23 | Buy |
| 50-day EMA: | 8.4 | Buy |
| 200-day EMA: | 8.72 | Buy |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
Maravai LifeSciences Holdings Earnings Growth & MRVI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.03 per share, and an increase next year of $0.07 per share.
Royalty Pharma PLC Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Maravai LifeSciences Holdings Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||